GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ISU Abxis Co Ltd (XKRX:086890) » Definitions » Common Stock

ISU Abxis Co (XKRX:086890) Common Stock : ₩17,951 Mil (As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is ISU Abxis Co Common Stock?

ISU Abxis Co's quarterly common stock increased from Mar. 2024 (₩17,385 Mil) to Jun. 2024 (₩17,834 Mil) and increased from Jun. 2024 (₩17,834 Mil) to Sep. 2024 (₩17,951 Mil).

ISU Abxis Co's annual common stock stayed the same from Dec. 2021 (₩16,591 Mil) to Dec. 2022 (₩16,591 Mil) but then increased from Dec. 2022 (₩16,591 Mil) to Dec. 2023 (₩17,306 Mil).


ISU Abxis Co Common Stock Historical Data

The historical data trend for ISU Abxis Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ISU Abxis Co Common Stock Chart

ISU Abxis Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13,312.65 14,132.32 16,591.33 16,591.33 17,305.62

ISU Abxis Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16,591.33 17,305.62 17,385.01 17,833.65 17,951.07

ISU Abxis Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


ISU Abxis Co Business Description

Traded in Other Exchanges
N/A
Address
3Fl. Kookje Bldg, 90-1 Daeshin-dong, Seodaemun-gu, Seoul, KOR, 120-160
ISU Abxis Co Ltd is engaged in developing and manufacturing therapeutic antibodies in South Korea. It offers Abciximab, Clotinab, Abcertin, and Fabagal used to treat incurable diseases such as cancer and rare diseases.

ISU Abxis Co Headlines

No Headlines